Dose escalation enzyme replacement therapy for treating acid sphingomyelinase deficiency
Details for Australian Patent Application No. 2010286550 (hide)
International Classifications
Event Publications
15 March 2012 PCT application entered the National Phase
PCT publication WO2011/025996 Priority application(s): WO2011/025996
3 May 2012 Alteration of Name
The name of the applicant has been altered to Mount Sinai School of Medicine; Genzyme Corporation
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2010286553-Stable acid denatured soy/urea adhesives and methods of making same
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser